FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2010596037> ?p ?o ?g. }

• W2010596037 endingPage "1613" @default.
• W2010596037 startingPage "1608" @default.
• W2010596037 abstract "Prevention of pre-invasive cervical lesions is an important benefit of HPV vaccines, but demonstrating impact on these lesions is impeded by changes in cervical cancer screening. Monitoring vaccine-types associated with lesions can help distinguish vaccine impact from screening effects. We examined trends in prevalence of HPV 16/18 types detected in cervical intraepithelial neoplasia 2, 3, and adenocarcinoma in situ (CIN2+) among women diagnosed with CIN2+ from 2008 to 2012 by vaccination status. We estimated vaccine effectiveness against HPV 16/18-attributable CIN2+ among women who received ≥1 dose by increasing time intervals between date of first vaccination and the screening test that led to detection of CIN2+ lesion. Data are from a population-based sentinel surveillance system to monitor HPV vaccine impact on type-specific CIN2+ among adult female residents of five catchment areas in California, Connecticut, New York, Oregon, and Tennessee. Vaccination and cervical cancer screening information was retrieved. Archived diagnostic specimens were obtained from reporting laboratories for HPV DNA typing. From 2008 to 2012, prevalence of HPV 16/18 in CIN2+ lesions statistically significantly decreased from 53.6% to 28.4% among women who received at least one dose (Ptrend < .001) but not among unvaccinated women (57.1% vs 52.5%; Ptrend = .08) or women with unknown vaccination status (55.0% vs 50.5%; Ptrend = .71). Estimated vaccine effectiveness for prevention of HPV 16/18-attributable CIN2+ was 21% (95% CI: 1–37), 49% (95% CI: 28–64), and 72% (95% CI: 45–86) in women who initiated vaccination 25–36 months, 37–48 months, and >48 months prior to the screening test that led to CIN2+ diagnosis. Population-based data from the United States indicate significant reductions in CIN2+ lesions attributable to types targeted by the vaccines and increasing HPV vaccine effectiveness with increasing interval between first vaccination and earliest detection of cervical disease." @default.
• W2010596037 created "2016-06-24" @default.
• W2010596037 creator A5000733810 @default.
• W2010596037 creator A5002541699 @default.
• W2010596037 creator A5005958976 @default.
• W2010596037 creator A5013657127 @default.
• W2010596037 creator A5036162420 @default.
• W2010596037 creator A5039180494 @default.
• W2010596037 creator A5039276242 @default.
• W2010596037 creator A5042070989 @default.
• W2010596037 creator A5070569046 @default.
• W2010596037 creator A5071992382 @default.
• W2010596037 creator A5077790322 @default.
• W2010596037 creator A5078442226 @default.
• W2010596037 creator A5080743666 @default.
• W2010596037 creator A5086208091 @default.
• W2010596037 creator A5091127124 @default.
• W2010596037 date "2015-03-01" @default.
• W2010596037 modified "2023-10-15" @default.
• W2010596037 title "Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States – 2008–2012" @default.
• W2010596037 cites W1876505025 @default.
• W2010596037 cites W1964509040 @default.
• W2010596037 cites W1976343694 @default.
• W2010596037 cites W2004767921 @default.
• W2010596037 cites W2025671366 @default.
• W2010596037 cites W2059879176 @default.
• W2010596037 cites W2063106601 @default.
• W2010596037 cites W2091752491 @default.
• W2010596037 cites W2102786052 @default.
• W2010596037 cites W2116021620 @default.
• W2010596037 cites W2123962939 @default.
• W2010596037 cites W2133525827 @default.
• W2010596037 cites W2136032688 @default.
• W2010596037 cites W2139736159 @default.
• W2010596037 cites W2160407895 @default.
• W2010596037 cites W2166632132 @default.
• W2010596037 cites W2166678252 @default.
• W2010596037 cites W2316172905 @default.
• W2010596037 doi "https://doi.org/10.1016/j.vaccine.2015.01.084" @default.
• W2010596037 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7522784" @default.
• W2010596037 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25681664" @default.
• W2010596037 hasPublicationYear "2015" @default.
• W2010596037 type Work @default.
• W2010596037 sameAs 2010596037 @default.
• W2010596037 citedByCount "101" @default.
• W2010596037 countsByYear W20105960372015 @default.
• W2010596037 countsByYear W20105960372016 @default.
• W2010596037 countsByYear W20105960372017 @default.
• W2010596037 countsByYear W20105960372018 @default.
• W2010596037 countsByYear W20105960372019 @default.
• W2010596037 countsByYear W20105960372020 @default.
• W2010596037 countsByYear W20105960372021 @default.
• W2010596037 countsByYear W20105960372022 @default.
• W2010596037 countsByYear W20105960372023 @default.
• W2010596037 crossrefType "journal-article" @default.
• W2010596037 hasAuthorship W2010596037A5000733810 @default.
• W2010596037 hasAuthorship W2010596037A5002541699 @default.
• W2010596037 hasAuthorship W2010596037A5005958976 @default.
• W2010596037 hasAuthorship W2010596037A5013657127 @default.
• W2010596037 hasAuthorship W2010596037A5036162420 @default.
• W2010596037 hasAuthorship W2010596037A5039180494 @default.
• W2010596037 hasAuthorship W2010596037A5039276242 @default.
• W2010596037 hasAuthorship W2010596037A5042070989 @default.
• W2010596037 hasAuthorship W2010596037A5070569046 @default.
• W2010596037 hasAuthorship W2010596037A5071992382 @default.
• W2010596037 hasAuthorship W2010596037A5077790322 @default.
• W2010596037 hasAuthorship W2010596037A5078442226 @default.
• W2010596037 hasAuthorship W2010596037A5080743666 @default.
• W2010596037 hasAuthorship W2010596037A5086208091 @default.
• W2010596037 hasAuthorship W2010596037A5091127124 @default.
• W2010596037 hasBestOaLocation W20105960372 @default.
• W2010596037 hasConcept C121608353 @default.
• W2010596037 hasConcept C126322002 @default.
• W2010596037 hasConcept C131872663 @default.
• W2010596037 hasConcept C203014093 @default.
• W2010596037 hasConcept C22070199 @default.
• W2010596037 hasConcept C2777343196 @default.
• W2010596037 hasConcept C2778220009 @default.
• W2010596037 hasConcept C2778580637 @default.
• W2010596037 hasConcept C2780009117 @default.
• W2010596037 hasConcept C2780647465 @default.
• W2010596037 hasConcept C2908647359 @default.
• W2010596037 hasConcept C29456083 @default.
• W2010596037 hasConcept C71924100 @default.
• W2010596037 hasConcept C99454951 @default.
• W2010596037 hasConceptScore W2010596037C121608353 @default.
• W2010596037 hasConceptScore W2010596037C126322002 @default.
• W2010596037 hasConceptScore W2010596037C131872663 @default.
• W2010596037 hasConceptScore W2010596037C203014093 @default.
• W2010596037 hasConceptScore W2010596037C22070199 @default.
• W2010596037 hasConceptScore W2010596037C2777343196 @default.
• W2010596037 hasConceptScore W2010596037C2778220009 @default.
• W2010596037 hasConceptScore W2010596037C2778580637 @default.
• W2010596037 hasConceptScore W2010596037C2780009117 @default.
• W2010596037 hasConceptScore W2010596037C2780647465 @default.
• W2010596037 hasConceptScore W2010596037C2908647359 @default.
• W2010596037 hasConceptScore W2010596037C29456083 @default.
• W2010596037 hasConceptScore W2010596037C71924100 @default.

• next